Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Stevanato Group Collaborates with Cambridge Design Partnership | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Stevanato Group Collaborates with Cambridge Design Partnership

The companies will develop a pen-injector for patients suffering from diabetes together.

By: Contract Pharma

Contract Pharma Staff

Stevanato Group, a producer of glass primary packaging and provider of integrated capabilities for combination products, and Cambridge Design Partnership (CDP), a UK- and U.S-based technology and product design partner, are collaborating to develop a new pen-injector based on the Axis-D technology and intellectual property (IP) licensed exclusively from Haselmeier in 2019.
 
The agreement leverages CDP’s design and development expertise in drug delivery devices, as well as Stevanato Group’s experience in glass containers, tooling, injection molding, device assembly and its global commercial network.
 
CDP and Stevanato Group will work together from the first concept right through design development, scale-up, regulatory submission, and commercial-scale production in all global markets. The collaboration supports Stevanato Group’s portfolio expansion of devices for patients suffering from diabetes.
 
“We are delighted to be announcing this partnership,” said Uri Baruch, CDP’s head of drug delivery. “Stevanato Group is well-established in the device field as a leading supplier of cartridges and assembly equipment for pen-injectors. It is a pleasure to extend our existing working relationship with them for their pen-injector and to address the needs of patients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics